ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2026
Subtracting First Principal Component May Improve 4R Tau Detectability on [
Ryota Satoh, Farwa Ali, Dennis W Dickson, Val J Lowe, Keith A Josephs, Jennifer L Whitwell
Abstract read
In one paragraphArticle in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Ryota SatohDepartment of Radiology, Mayo Clinic, Rochester, Minnesota; satoh.ryota@mayo.edu.
Farwa AliDepartment of Neurology, Mayo Clinic, Rochester, Minnesota; and.
Dennis W DicksonDepartment of Neuroscience, Mayo Clinic, Jacksonville, Florida.
Val J LoweDepartment of Radiology, Mayo Clinic, Rochester, Minnesota.
Keith A JosephsDepartment of Neurology, Mayo Clinic, Rochester, Minnesota; and.
Jennifer L WhitwellDepartment of Radiology, Mayo Clinic, Rochester, Minnesota.
Funding
Longitudinal multi-modality imaging in progressive apraxia of speech (Diversity Supplement)R01DC012519 · NIDCD · MAYO CLINIC ROCHESTER · PI Jennifer Louise Whitwell · 2013 to 2026
$7.2MLongitudinal Multi-modal Imaging in Progressive Supranuclear Palsy SyndromesR01NS089757 · NINDS · MAYO CLINIC ROCHESTER · PI JOSEPHS, KEITH A, WHITWELL, JENNIFER LOUISE · 2015 to 2024
$5.6MLongitudinal multi-modal imaging in progressive supranuclear palsy syndromesR37NS089757 · NINDS · MAYO CLINIC ROCHESTER · PI Keith A Josephs, Jennifer Louise Whitwell · 2026 to 2026
$3.7MFlortaucipir PET and histopathology in frontotemporal lobar degeneration and Alzheimer’s diseaseR01NS112153 · NINDS · MAYO CLINIC ROCHESTER · PI JOSEPHS, KEITH A, WHITWELL, JENNIFER LOUISE · 2024 to 2025
$767kNIDCD NIH HHS R01 DC012519NINDS NIH HHS R01 NS089757NINDS NIH HHS R01 NS112153NINDS NIH HHS R37 NS089757
6 · The paper itselfAbstract
Indexed as
CarbolinesPositron-Emission TomographyPrincipal Component Analysistau ProteinsAgedFemaleHumansMaleMiddle AgedSensitivity and SpecificitySupranuclear Palsy, Progressive7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indoleCarbolinestau Proteins[18F]flortaucipir4R tauprincipal component analysisPSP
Identifiers
PMID41571432
PMCPMC13041585
What OpenQuestion holds
Textmetadata
Read underepoch 390